Skip to content
Search

Latest Stories

As costs rise, Rowlands to review opening hours of pharmacies

Rowlands Pharmacy on Monday announced a proposal to review opening hours across its pharmacies in England.

Calling it a move towards the core hours it is contracted to provide, the Phoenix group-owned pharma chain said it can no longer sustain the cost of opening beyond core contracted hours.


“Rowlands has proposed this change as a direct consequence of the funding austerity facing community pharmacy in England which has made the network economically unsustainable. Government funding for community pharmacy in England has been capped over the next five years which in real terms, taking account of rising costs and inflation, means a reduction in funding,” the company said in a statement.

However, the proposal does not apply to Rowlands’ pharmacies in Scotland and Wales as the funding there “are more robust”.

The multiple anticipates the changes to result in a reduction of 10 hours per branch on average each working week with minimal impact on customers.

The proposal is currently being discussed with the pharmacy staff and a final decision is expected by the end of the month.

“Rowlands reiterates that with a pledge of £34bn in new funding for the NHS now is the time for the Government to invest in community pharmacy and reverse the decline in the network which has seen hundreds of pharmacies close at a time when GP surgeries and A&E departments are struggling to cope with demand,” the statement further added.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less